(NURS) Hydreight Technologies - Ratings and Ratios
Exchange: V • Country: United States • Currency: CAD • Type: Common Stock •
NURS: Health, Wellness, Consulting, Pharmaceutical, App, Insurance, Services
Hydreight Technologies Inc. (V:NURS) is a U.S.-based company specializing in mobile health and wellness solutions. Their Hydreight App serves as a comprehensive platform for healthcare providers, offering consulting services that streamline the setup and operation of wellness practices. The app provides access to legal advisors skilled in medical and privacy law, assists with medical liability insurance, and offers vetted pharmaceutical IV programs overseen by licensed pharmacists. Additionally, it includes procedural guides for services like Botox and fillers, along with operational support in hiring, onboarding, training, marketing, branding, payroll, and accounting. The company also operates a health-related application and engages in pharmaceutical sales, distributing products to clinics and medical spas. Headquartered in Las Vegas, Nevada, Hydreight Technologies aims to enhance operational efficiency and regulatory compliance for healthcare providers.
Looking ahead, Hydreight Technologies stock (V:NURS) is expected to show volatility. Technically, the stock is currently below its 20 and 50-day moving averages but above its 200-day moving average, indicating potential short-term weakness but longer-term strength. The Average True Range (ATR) of 0.27 suggests moderate price movement. Fundamentally, with a market cap of 54.40M CAD and a price-to-sales ratio of 3.54, the company may focus on expanding its market share and improving profitability. The high return on equity (RoE) of 73.32% highlights efficient equity use, which could attract investors. Over the next three months, if the stock maintains above the 200-day SMA, a recovery towards the 20-day SMA is possible. Conversely, a drop below the 200-day SMA could lead to testing lower support levels. The companys focus on partnerships and new service offerings may drive future growth.
Additional Sources for NURS Stock
NURS Stock Overview
Market Cap in USD | 30m |
Sector | Healthcare |
Industry | Health Information Services |
GiC Sub-Industry | Health Care Technology |
IPO / Inception |
NURS Stock Ratings
Growth 5y | 34.0% |
Fundamental | 18.0% |
Dividend | 0.0% |
Rel. Strength Industry | 324 |
Analysts | - |
Fair Price Momentum | 1.17 CAD |
Fair Price DCF | - |
NURS Dividends
No Dividends PaidNURS Growth Ratios
Growth Correlation 3m | -36% |
Growth Correlation 12m | 74.8% |
Growth Correlation 5y | -3.8% |
CAGR 5y | 32.70% |
CAGR/Max DD 5y | 0.43 |
Sharpe Ratio 12m | -0.04 |
Alpha | 289.52 |
Beta | 0.97 |
Volatility | 146.80% |
Current Volume | 3.6k |
Average Volume 20d | 65.1k |
As of March 16, 2025, the stock is trading at CAD 1.24 with a total of 3,600 shares traded.
Over the past week, the price has changed by +16.98%, over one month by -4.62%, over three months by +24.00% and over the past year by +327.59%.
Neither. Based on ValueRay Fundamental Analyses, Hydreight Technologies is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 18.01 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NURS as of March 2025 is 1.17. This means that NURS is currently overvalued and has a potential downside of -5.65%.
Hydreight Technologies has no consensus analysts rating.
According to ValueRays Forecast Model, NURS Hydreight Technologies will be worth about 1.3 in March 2026. The stock is currently trading at 1.24. This means that the stock has a potential upside of +7.26%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 1.3 | 7.3% |